Characterization of Non- Specific Hepatoxicity Related to Trastuzumab Emtansine (T-DM1) in Rodent & Human Hepatocytes

Time: 12:00 pm
day: Track B - Pre-Conf- PM

Details:

  • Brief overview of ADC-related toxicities
  • Sharing in vitro and in vivo toxicity data
  • Discussing the importance of selecting the appropriate preclinical model for ADC toxicity assessment and implication on clinical development

Speakers: